Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Axogen Inc (AXGN) vs iShares Global Tech ETF (IXN) Price & Performance

Axogen IncTrade
iShares Global Tech ETFTrade

Price performance (Past 24H)

Key statistics

Axogen Inc vs iShares Global Tech ETF — how do they compare? Axogen Inc trades at $49.16 (market cap $2.61B), while iShares Global Tech ETF trades at $142.41. The key difference: Axogen Inc is trading nearer its 52-week high, iShares Global Tech ETF nearer its low. Which is the better fit depends on your goals.

AXGNIXN
Market Cap
$2.61B
Sector
TechnologySector/Thematic
52-Week High
$48.48$149.74
52-Week Low
$14.16$94.42
Enterprise Value
$2.52B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Axogen Inc

AXGN trades at $48.53, up 0.64% today, with a bullish technical signal from moving averages and strong analyst support. Q2 2026 revenue grew 23.1% to $69.7M, beating estimates, and full-year guidance was raised to at least $279M. However, the company remains unprofitable with a net income margin of -13.36% and negative ROE, reflecting high SG&A costs relative to revenue.

The outlook is mixed: robust revenue growth and FDA-backed nerve care platform expansion offer upside, but persistent losses and high valuation multiples (P/S 9.57) pose risks. With 84% analyst buy ratings and a $54.33 price target, near-term momentum depends on execution toward profitability amid competitive and reimbursement pressures.

iShares Global Tech ETF

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About Axogen Inc

Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.

Read more on AXGN

About iShares Global Tech ETF

IXN provides exposure to global electronics, software, and hardware companies. It tracks the S&P Global 1200 Information Technology Index, covering tech leaders across both developed and emerging markets.

Read more on IXN